| abstract |
The disclosure provides (a) compounds and salts that specifically inhibit RSV infection and / or replication; (b) intermediates useful in the manufacture of such compounds and salts; (c) compositions comprising such compounds and salts. (D) methods for producing such intermediates, compounds, salts and compositions; (e) methods for using such compounds, salts and compositions; and (f) such compounds, salts and compositions. It is related with the kit containing. |